INDV
Price
$34.46
Change
+$0.12 (+0.35%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
4.29B
21 days until earnings call
Intraday BUY SELL Signals
IRWD
Price
$4.44
Change
-$0.05 (-1.11%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
728.8M
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INDV vs IRWD

Header iconINDV vs IRWD Comparison
Open Charts INDV vs IRWDBanner chart's image
Indivior Pharmaceuticals
Price$34.46
Change+$0.12 (+0.35%)
Volume$21.86K
Capitalization4.29B
Ironwood Pharmaceuticals
Price$4.44
Change-$0.05 (-1.11%)
Volume$28.87K
Capitalization728.8M
INDV vs IRWD Comparison Chart in %
INDV
Daily Signal:
Gain/Loss:
IRWD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INDV vs. IRWD commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Buy and IRWD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 06, 2026
Stock price -- (INDV: $34.34 vs. IRWD: $4.49)
Brand notoriety: INDV and IRWD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INDV: 44% vs. IRWD: 55%
Market capitalization -- INDV: $4.29B vs. IRWD: $728.8M
INDV [@Pharmaceuticals: Generic] is valued at $4.29B. IRWD’s [@Pharmaceuticals: Generic] market capitalization is $728.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 0 FA rating(s) are green whileIRWD’s FA Score has 0 green FA rating(s).

  • INDV’s FA Score: 0 green, 5 red.
  • IRWD’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 5 TA indicator(s) are bullish while IRWD’s TA Score has 2 bullish TA indicator(s).

  • INDV’s TA Score: 5 bullish, 4 bearish.
  • IRWD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, INDV is a better buy in the short-term than IRWD.

Price Growth

INDV (@Pharmaceuticals: Generic) experienced а -1.69% price change this week, while IRWD (@Pharmaceuticals: Generic) price change was -6.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.85%. For the same industry, the average monthly price growth was -2.19%, and the average quarterly price growth was +12.81%.

Reported Earning Dates

INDV is expected to report earnings on Feb 26, 2026.

IRWD is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.85% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($4.29B) has a higher market cap than IRWD($729M). INDV has higher P/E ratio than IRWD: INDV (35.04) vs IRWD (24.89). IRWD YTD gains are higher at: 33.086 vs. INDV (-4.292). INDV has higher annual earnings (EBITDA): 267M vs. IRWD (129M). INDV has more cash in the bank: 445M vs. IRWD (140M). INDV has less debt than IRWD: INDV (356M) vs IRWD (598M). INDV has higher revenues than IRWD: INDV (1.18B) vs IRWD (339M).
INDVIRWDINDV / IRWD
Capitalization4.29B729M589%
EBITDA267M129M207%
Gain YTD-4.29233.086-13%
P/E Ratio35.0424.89141%
Revenue1.18B339M348%
Total Cash445M140M318%
Total Debt356M598M60%
FUNDAMENTALS RATINGS
INDV vs IRWD: Fundamental Ratings
INDV
IRWD
OUTLOOK RATING
1..100
275
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
35100
SMR RATING
1..100
63100
PRICE GROWTH RATING
1..100
3834
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRWD's Valuation (64) in the Pharmaceuticals Other industry is in the same range as INDV (91) in the null industry. This means that IRWD’s stock grew similarly to INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (35) in the null industry is somewhat better than the same rating for IRWD (100) in the Pharmaceuticals Other industry. This means that INDV’s stock grew somewhat faster than IRWD’s over the last 12 months.

INDV's SMR Rating (63) in the null industry is somewhat better than the same rating for IRWD (100) in the Pharmaceuticals Other industry. This means that INDV’s stock grew somewhat faster than IRWD’s over the last 12 months.

IRWD's Price Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as INDV (38) in the null industry. This means that IRWD’s stock grew similarly to INDV’s over the last 12 months.

IRWD's P/E Growth Rating (99) in the Pharmaceuticals Other industry is in the same range as INDV (100) in the null industry. This means that IRWD’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVIRWD
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 21 days ago
68%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INDV
Daily Signal:
Gain/Loss:
IRWD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPLIX17.240.19
+1.11%
Calamos Phineus Long/Short I
MEIJX52.150.42
+0.81%
MFS Value R4
DPREX14.540.09
+0.62%
Nomura Global Listed Real Assets A
TSVRX20.140.05
+0.25%
PGIM Quant Solutions Small-Cap Val R
MAFGX40.56-0.84
-2.03%
BlackRock Capital Appreciation Instl

INDV and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDV has been loosely correlated with ASRT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INDV jumps, then ASRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
-3.13%
ASRT - INDV
58%
Loosely correlated
-1.17%
AMRX - INDV
53%
Loosely correlated
+1.26%
TAK - INDV
51%
Loosely correlated
+1.78%
TEVA - INDV
51%
Loosely correlated
-3.56%
COLL - INDV
51%
Loosely correlated
+1.41%
More

IRWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRWD has been loosely correlated with TEVA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IRWD jumps, then TEVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-6.37%
TEVA - IRWD
58%
Loosely correlated
-3.56%
VTRS - IRWD
53%
Loosely correlated
+4.97%
INDV - IRWD
44%
Loosely correlated
-3.13%
BIOA - IRWD
40%
Loosely correlated
+1.21%
ALKS - IRWD
31%
Poorly correlated
-0.99%
More